4-aminopyridine has been researched along with Vitreoretinopathy, Proliferative in 1 studies
Vitreoretinopathy, Proliferative: Vitreoretinal membrane shrinkage or contraction secondary to the proliferation of primarily retinal pigment epithelial cells and glial cells, particularly fibrous astrocytes, followed by membrane formation. The formation of fibrillar collagen and cellular proliferation appear to be the basis for the contractile properties of the epiretinal and vitreous membranes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bringmann, A | 1 |
| Francke, M | 1 |
| Pannicke, T | 1 |
| Biedermann, B | 1 |
| Faude, F | 1 |
| Enzmann, V | 1 |
| Wiedemann, P | 1 |
| Reichelt, W | 1 |
| Reichenbach, A | 1 |
1 other study available for 4-aminopyridine and Vitreoretinopathy, Proliferative
| Article | Year |
|---|---|
Human Müller glial cells: altered potassium channel activity in proliferative vitreoretinopathy.
Topics: 4-Aminopyridine; Adolescent; Adult; Aged; Aged, 80 and over; Calcium; Electrophysiology; Female; Hum | 1999 |